Posted by & filed under Company Analysis, Governments & Regulators, Growth & Valuation, Industry Analysis, Personal Finance.

Description: A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation’s opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months. But litigation is sure to continue against the company and the family that owns it.

Source: – video report

Date: Sep 11, 2019


Questions for discussion:

  • What is the message presented here to the players involved?
  • which other industries face similar issues?
  • What are the ethical issues that the industry needs to consider?

Leave a Reply

Your email address will not be published. Required fields are marked *